In a new study, researchers from the University of Maryland, Baltimore County (UMBC) have developed tools to improve the analysis of functional magnetic resonance imaging (fMRI) data, and as a result are now able to identify subgroups of schizophrenia patients.
The new findings can assist in diagnosis and treatment of patients with mental illnesses that can be difficult to identify and show medical practitioners whether the current treatments have or have not been working based on image groupings.
The study is published in the journal NeuroImage.
The image analysis method is called independent vector analysis (IVA) for common subspace extraction (CS). Through this method, the researchers were able to categorize subgroups of fMRI data based solely on brain activity, proving that there is a link between brain activity and certain mental illnesses. In particular, they were able to identify subgroups of schizophrenia patients by analyzing the fMRI data.
Previously, there has been no clear way to group schizophrenia in patients based on brain imaging alone, but the new method demonstrates a significant connection between a patient’s brain activity and their diagnoses.
“The most exciting part is that we found out the identified subgroups possess clinical significance by looking at their diagnostic symptoms,” said Qunfang Long, a Ph.D. candidate at UMBC in electrical engineering. “This finding encouraged us to put more effort into the study of subtypes of patients with schizophrenia using neuroimaging data.”
Importantly, the IVA-CS method used to identify these subgroups also preserves nuances in the data, but still renders statistically significant groupings.
“Now that data-driven methods have gained popularity, a big challenge has been capturing the variability for each subject while simultaneously performing analysis on fMRI datasets from a large number of subjects,” said Dr. Tülay Adali, professor of computer science and electrical engineering and director of UMBC’s Machine Learning for Signal Processing Lab.
“Now we can perform this analysis effectively, and can identify meaningful groupings of subjects.”
Diagnosing and treating mental illness is incredibly complex. The same illness will present differently in different patients, and there is often no singular treatment that will be effective for all patients. Once a treatment is in place, determining if it is successful can also vary by patient.
This research responds to variability by giving medical practitioners an objective way to analyze the fMRI results for patients within relatively similar diagnostic subgroups, and then compare fMRI results over time for the same patient.
Consider a schizophrenic patient who receives treatment and returns in six months to be evaluated again. If their fMRI data resembles that of the control group of mentally healthy patients more than that of other patients with schizophrenia, that is objective evidence that the treatment is working. On a larger scale, this data provides a better look at patients’ medical outcomes as a result of treatment.
Next, Adali’s team will work with longitudinal data to determine which treatments work best for subgroups of patients with specific mental illnesses. This method will also be used in a longitudinal study of adolescents to see whether there are links between fMRI images and the addiction and substance use patterns of those adolescents over time.
Adali and Long’s current research is with longtime collaborator Dr. Vince Calhoun at the Tri-institutional Center for Translational Research in Neuroimaging and Data Science in Atlanta.
Source: PsychCentral New Analysis of fMRI Data May Hone Schizophrenia Treatment